Molecular, functional, and clinical analyses strongly suggest that chromosome segment 11p15.5 contains a gene involved in lung cancer pathogenesis. The critical region of allele loss is 310 kb in size. We used our contig of P1-phage arti®cial chromosome (PAC) clones together with newly identi®ed bacterial arti®cial chromosome (BAC) clones and the draft human genome sequence to complete a contiguous string of 380 407 bp. Three PAC clones that span the region were used to identify transcripts by exon trapping. Computational gene prediction algorithms were used to query the sequence for potential genes and exons. Screening for expression was performed with tissue-speci®c and cell line derived mRNA arrays. The region contains the complete SSA/Ro52 and RRM1 genes, exons 7 ± 12 of the GOK gene, and the crad pseudo-gene. A cluster of six nearly identical genes with an intact open reading frame (ORF) of 585 bp that share 75% identity with the HSPC182 gene was found. In addition, ®ve putative novel genes were identi®ed. Sequence tagged sites (STS) and polymorphic markers were used to screen 117 lung cancer cell lines for homozygous deletions and none were identi®ed. These data provide the basis for the identi®cation of a lung cancer suppressor gene on 11p15.5. Oncogene (2001) 20, 8154 ± 8164.
Introduction
Chromosome segment 11p15.5 contains two regions of frequent loss of heterozygosity (LOH) in non-small-cell lung cancer (non-SCLC) (reviewed in . A detailed contig of P1-phage and bacterial arti®cial chromosomes (PAC and BAC) for the proximal region of LOH on 11p15.5, designated as LOH11A, has been reported . The minimal region of LOH was 650 kb and¯anked by the markers D11S988 (centromeric) and D11S860 (telomeric). Numerous investigators have reported LOH in this region for non-SCLC with frequencies ranging from 17% to 82% (Bepler and Garcia-Blanco, 1994; Fong et al., 1994; Ludwig et al., 1991; Shiraishi et al., 1987; Skinner et al., 1990; Tran and Newsham, 1996; Weston et al., 1989) . LOH in or near this region has also been described for breast, ovarian, esophageal, stomach, and other cancers arising in adults (Ali et al., 1987; Fearon et al., 1985; Karnik et al., 1998; Lu et al., 1997; Ranzani et al., 1993; Shibagaki et al., 1994; Tran and Newsham, 1996; Viel et al., 1992; Winqvist et al., 1993) . Together, these malignancies account for approximately 500 000 new cancer cases in the United States annually (Greenlee et al., 2001) .
Structural and numerical chromosome aberrations involving chromosome segment 11p15 have also been observed in non-SCLC by cytogenetic analysis, although speci®c deletions or translocations within 11p15.5 have not been described (Bepler and Koehler, 1995; Lukeis et al., 1990; Whang-Peng et al., 1991) . Homozygous allele loss within or near the LOH11A region, which would allow for further re®nement of the region, has not been described. We suggested that this might in part be explained by the presence of the RRM1 gene in the minimal region of LOH. This gene encodes the large subunit of ribonucleotide reductase, and at least one functional copy of this gene is required for cells to maintain deoxynucleotide pools for DNA replication and repair and thus maintenance of the malignant phenotype .
Further evidence for the loss of a biologically important gene in lung cancer in this region was provided by genetic complementation studies. Introduction of a whole chromosome 11 into the lung cancer cell line A549 resulted in tumor suppression (Satoh et al., 1993) , and chromosome transfer of a radiation-reduced fragment of 11p15 that contained the minimal region of LOH into the lung adenocarcinoma cell line ADLC-5M2 likewise resulted in tumor suppression (O'Briant et al., 1997) . Finally, we have reported that LOH for a marker located within the region, D11S12, is associated with increased metastatic spread in patients with non-SCLC (Bepler et al., 1998 ) and a signi®cantly shortened survival for patients with pathologic stage I of the disease .
We have recently reduced the minimal region of allele loss to 310 kb, between the markers SSA44 and RR37 Kim et al., 2000) . Two genes, SSA/Ro52 and RRM1, within this minimal region of LOH have been studied for potential inactivating mutations, and none were identi®ed Pitterle et al., 1999) . Few other expressed sequence tags (ESTs) and putative genes have been localized to this region . In order to search for additional genes we have assembled a contiguous genomic sequence of 380 407 bp by sequencing 262 916 bp and using the draft human genome sequence to ®ll in the remaining 117 491 bp. We completed a transcript map using exon trapping and computational exon prediction algorithms. The results presented here should enable investigators to conduct functional analyses for candidate genes.
Results

Complete genomic sequence assembly
The evidence for a tumor suppressor gene on chromosome segment 11p15.5 involved in lung cancer is overwhelming but few genes were identi®ed in the critical LOH11A region at the outset of this project. We had previously generated subclones of the PAC contig (113G22, 28C6, 267B3) that spanned the smallest region of allele loss by complete EcoRI digestion and ligation into pGEM-4Z . In all, 62 subclones were sequenced. They were aligned in series by direct sequencing of the EcoRI junctions between subclones using the PAC contig clones as templates. This resulted in three sequence contigs of 82 761 bp (Group I in Figure 1 , GenBank accession number AF391283), 19 956 bp (Group II in Figure 1 GenBank accession number AF391284), and 160 199 bp (Group III in Figure 1 , GenBank accession number AF391285).
To ®ll the two gaps of approximately 45 kb and 84 kb, we screened the draft human genome sequence (Consortium, 2001 ) and identi®ed four human BAC clones (RP11-101E4, RP11-437G21, RP11-462E16, and RP11-23F23) that allowed us to improve the depth of the regional map (Figure 1 ). The sequences of each of these BAC clones were available as 10 or 20 sequence contigs in GenBank in December 2000. To align these contigs, we cloned partially Sau3AI-digested DNA from these BAC clones into pBluescript and endsequenced the resulting subclones. This allowed us to align the BAC sequence contigs and to ®ll the two gaps shown in Figure 1 . The entire region covered by the PAC clones 113G22, 28C6, and 267B3 is 380 407 bp in size, and actual sizes of the two gaps were 40 659 bp (GenBank accession number AC018793) and 76 832 bp (GenBank accession number AC016035). This is within 1.8% of the previously estimated size of 387 500 bp, which was based on STS and restriction enzyme mapping .
As a result of this eort, it was possible to identify two complete genes (SSA/Ro52 and RRM1), one partial gene (GOK), and one pseudo-gene (crad) in the region. Their location and orientation are shown in Figure 2 . In addition, one complete and previously unidenti®ed human endogenous retroviral (HERV) element was found.
Transcripts identified by exon trapping
To ®nd further genes in the region we used exon trapping from the three PAC contig clones (113G22, 28C6, and 267B3). Of the total of 160 clones with putatively trapped exons, 55 contained unique transcripts that mapped to the genomic DNA in the region. The location of each of these 55 exons is shown in Figure 2 , and Table 1 provides a detailed summary including matches observed with a BLAST analysis in GenBank.
Twenty-one exons belonged to known genes in the region, ®ve to SSA/Ro52, 13 to RRM1, and three to GOK. The last exon of RRM1 (#19) and exon #10 were partially recovered, all others were complete internal exons. We have thus obtained 20 of the 28 internal exons that could have been isolated with this technique. Of the 34 remaining exons, 10 were part of the LINE-1 repeats, eight were part of HERVs, and 16 were novel exons, which were further studied for 
Gene prediction by computational analysis
To obtain additional information on exons and potential novel genes, we queried the entire genomic sequence of 380 407 bp with the programs GrailEXP and GENSCAN. Putative genes and exons identi®ed with these two programs are shown in Figure 2 . GrailEXP (version 3.2) predicted 23 genes in the region (see Table 2 ). Thirteen oriented from centromere to telomere and 10 in reverse. The number of exons ranged from 1 ± 19 per predicted gene, and the total number was 63. All exons of the genes SSA/Ro52, RRM1, and GOK were accurately predicted with the exception of the ®rst and last exon and one internal exon each for RRM1 (exon 11) and for GOK (exon 6). These were in the correct map position but the predicted sizes were larger (1 ± 180 nucleotides) than those reported in GenBank. The crad pseudo-gene was detected as two exons separated by 55 bp, and a comparison of the human radixin mRNA (NM_002906) with the entire genomic sequence resulted in a near perfect match without introns. Six of the predicted single-exon genes (#8 ± 11, #13, #14) had 75% identity with nucleotides 66 ± 650 of the human heat shock protein C182 mRNA (NM014188). The mismatches included one deletion, one insertion, and 140 substitutions; however, none of these disturbed the 585 bp ORF. These putative genes were arranged in three groups separated by 45 kb and 51 kb respectively. In each group, two HSPC182-like genes were oriented end-to-end approximately 9 kb apart. Of the 55 transcripts identi®ed by exon trapping, 25 were also found by GrailEXP. These included the 21 exons that are part of known genes. The remaining four transcripts (#12, #29, #35, #37 in Table 1 ) were predicted as parts of four novel genes (see Figure 2) . GENSCAN (version 1.0) predicted 22 genes, 13 in forward and nine in reverse orientation (see Table 3 ). The number of exons ranged from 1 ± 33 per gene, and the total number of predicted exons was 93 (see Figure  2 ). This program accurately predicted exons 3 ± 6 of SSA/Ro52, exons 2 ± 18 of RRM1, and exons 6 ± 10 of GOK. Exons 2 and 7 of SSA/Ro52, exons 1 and 19 of RRM1, and exon 12 of GOK were also predicted, albeit smaller than reported in GenBank, and the program did not predict exon 1 of SSA/Ro52 and exon 11 of GOK. Also, the genes RRM1 and GOK were predicted as one large gene with more than 33 exons. Sequences that are part of the crad pseudo-gene were identi®ed as belonging to a 9-exon gene (#18 in Table 3 ). Twentythree of the 55 transcripts found with exon trapping were also found by GENSCAN, of which 19 belonged to the three known genes. The four remaining transcripts (#23, #29, #35, #37 in Table 1 ) were predicted as exons belonging to three genes (see Figure  2 ).
Three transcripts identi®ed by exon trapping (#29, #35, #37 in Table 1) were also predicted by GrailEXP and GENSCAN; and 10 exons that were predicted by both, GENSCAN and GrailEXP, were not recovered by exon trapping (see Figure 2 ). In all of these cases, the size predictions diered slightly among these methods, with one exception. Transcript #35 was predicted by all three methods to be 180 bp.
Genie (version 12/96) predicts one multi-exon gene in forward and reverse orientation for every sequence fragment analysed. The entire sequence was thus queried in 20 kb and in 80 kb fragments. With the 19 20 kb fragments, a total of 91 exons were identi®ed in 38 genes (2 ± 9 exons per gene). With the ®ve 80 kb fragments, a total of 49 exons were identi®ed in 10 genes (2 ± 22 exons per gene). This program identi®ed 2/7 SSA/Ro52 exons, 10/19 RRM1 exons, and 6/7 GOK exons. Three of these 18 exons diered from the published sizes, and all 18 were internal exons. None of the exon trapping transcripts were identi®ed with this method. These results are not included in Figure 2 .
Expression analysis and library screening
To obtain evidence for expression of these putative transcripts and predicted genes, we focused primarily Figure 2 Precise map of the LOH11A region based on sequencing. The restriction sites, STSs, and polymorphic markers are shown below the ruler. Known genes within this region are placed immediately above the ruler. Exons within genes are indicated by bright red bars, and the orientation of genes is provided by black arrows. Eleven putative novel genes are depicted as red diamonds below the ruler. Genes and exons identi®ed by dierent methods are shown as green bars (orientation centromere to telomere), red bars (orientation telomere to centromere), or white bars (exons belonging to the known genes in the region). Sequences identi®ed as putative exons by several methods are indicated by double arrows (left, centromere; right, telomere)
Transcript map and sequence of non-SCLC LOH region B Zhao and G Bepler on exons that were predicted by multiple methods. Results are summarized in Table 4 . For an initial screening evaluation of expression, we used six cDNAs generated from total RNA of cell lines (prostate cancer ± LNCaP, and lung cancer ± ADLC-5M2, NCI-H23, SCLC-22H, SCLC-24H, MSTO-211H) and three cDNA libraries (fetal lung, adult lung, and whole fetus) as templates in PCR reactions with primers that were designed to amplify products within a single exon.
In addition, we designed primers to cross potential introns between two neighboring exons that belonged to the same putative mRNA species. Transcripts with speci®c PCR products were then subjected to a secondary and tertiary screening for expression. For this, probes were generate from PCR products and used to screen for expression in multiple tissue expression (MTE) array and Northern blots. Primers spanning exons 8 ± 12 of RRM1 (forward: Figure 3 . There were weak signals on the MTE arrays for exons #8 ± 9, #29, and #37 with mRNA derived from lymph nodes. It is possible that exons #8 ± 9 and #29 are part of same gene because they are oriented in the same direction (centromere to telomere). However, exon #37 must be part of a separate gene; its orientation is telomere to centromere. A single probe generated for exons #32 ± 34 and a probe speci®cally generated for exon #33 resulted in the same hybridization pattern (liver, prostate, testis, leukemia cell line K-562). This suggests that these three exons are part of the same gene. Exon #35, which was Figure 3 ) speci®c for one of the six single-exon genes (#8 ± 11, #13, #14, see Table 2 ) predicted by GrailEXP with 75% sequence identity with the human heat shock protein C182 hybridized with mRNA derived from lymph node, testis, and liver. This suggests that as many as 6 HSPC182-like genes may be located in the critical region of allele loss.
Northern blots were done to further corroborate that these exons are parts of expressed genes. Speci®c and distinct bands were obtained with probes for exons GS #16, ET #33, ET #37 (see Figure 4) , and RRM1 (data not shown), which suggests that they are part of three separate genes. The other exons did not yield signals on Northern blots.
All other exons identi®ed by exon trapping did not show evidence for expression in the tissues and cell lines examined or showed patterns consistent with that of human repetitive elements (data not shown). Exons #5 and #11 were not evaluated because of their small size.
Allelotyping and assessment for homozygous deletions of lung cancer cell lines
To obtain further evidence for allele loss in the region and to screen for possible homozygous deletions, which may enable investigators to further re®ne the search for a tumor suppressor gene, we performed allelotyping on 117 well characterized human lung cancer cell lines. These included 61 non-SCLC and 56 SCLC cell lines.
Allelotyping results for the polymorphic loci SSA44 (map position 54 kb), D11S4932 (map position 261 kb), RRI9 (map position 327 kb), and RR37 (map position 355 kb) are summarized in Table 5 . The frequency of heterozygosity in the combined group of lung cancer cell lines was signi®cantly lower for the two markers D11S4932 (P50.001) and RRI9 (P40.001) compared to their expected frequencies using the Chi-square test of independence. The frequency of heterozygosity for the markers SSA44 and RR37 was not dierent from the expected rate. These data con®rm that allele loss in the region is a frequent event in lung cancer.
We also performed a screen of these cell lines for homozygous deletions at the same loci and an additional three loci with STS markers (STS113, map position 63 kb; STS28, map position 233 kb; STS10, map position 282 kb). PCR products of the expected sizes for all markers were obtained indicating that homozygous deletions are not present in this set of lung cancer cell lines (data not shown).
Discussion
We have assembled a contiguous sequence of 380 407 bp for the minimal region of frequent allele loss in lung cancer on chromosome segment 11p15.5 (LOH11A). Polymorphic markers, known genes, and genes and exons identi®ed by exon trapping and computational gene prediction algorithms were precisely mapped. This provides a sound basis for the identi®cation and functional analysis of genes in the region that may play a role in the pathogenesis of lung cancer. Functional analyses by microcell-mediated chromosome transfer and clinical studies have suggested that loss of this critical region results in a more aggressive tumor phenotype (Bepler et al., 1998 O'Briant et al., 1997) , and analysis of two known genes, SSA/Ro52 and RRM1, has not provided evidence for mutational inactivation Pitterle et al., 1999) .
The human genome project has recently provided a draft sequence of the human genome. As of December 2000, the complete sequence of BAC clones for the LOH11A region was available as 10 ± 20 sequence Number of exons identi®ed with respective technique; ND, not determined contigs for the respective clones. Our sequencing eorts of EcoRI fragments derived from PAC clones that span the region and of partially digested Sau3AI fragments of BAC clones allowed us to assemble six sequence contigs from the available GenBank data. The ®rst of ®ve gaps (1576 bp) was ®lled with BACderived sequences and the remaining four gaps (197 bp, 271 bp, 166 bp, 211 bp) were ®lled with PAC-derived sequences. In addition, the contig contains four small regions, each approximately 100 bp in size, which were ®lled with 100 Ns respectively (#209037 ± 209136, #339029 ± 339128, #342516 ± 342615, #370274 ± 370373). The size estimate is based on PCR fragment analysis, and sequences for these gaps could not be resolved using various modi®cations of sequencing protocols including manual sequencing. Given the small size of each of these gaps and the fact that sequences that cannot be resolved by current technology are likely repeats, it is highly unlikely that these four gaps contain crucial genetic information. We thus constructed a contiguous string of sequence for the entire region. This 380 407 bp sequence was only 1.8% shorter than the predicted size of 387.5 kb that was based on size determination of PAC and BAC clones Figure 3 Hybridization pattern of transcripts identi®ed by exon trapping and computational analysis on multiple tissue expression array blots. All blots were exposed to phosphor screens for 44 ± 72 h. Exons #8 ± 9, #29, and #37 showed weak positivity with lymph node-derived mRNA (F7). Exon #16 hybridized with lymph node (F7), testis (F8), and liver (A9). Exon #33 and exons #32 ± 34 were positive with prostate (E8), testis (F8), liver (A9), and the leukemia cell line K-562 (C10). Exon #35 hybridized with lymph node (F7), prostate (E8), testis (F8), and liver (A9). All probes were positive with human genomic DNA. Probes for human repetitive DNA and for the RRM1 gene were used as positive controls (data not shown). Both showed various degrees of hybridization with all 76 RNA specimens, and the repetitive DNA probe hybridized strongest with F12 (human repetitive DNA) and H12 (human genomic DNA). Columns 1 ± 11 contain poly-A RNA from 76 dierent human tissues and cell lines; 1 ± 3 are from the central nervous system, 4 is from the heart and aorta, 5 ± 6 are from the gastrointestinal tract, 7 ± 9 are from various other organs, 10 is from cell lines, and 11 is from fetal tissues. Column 12 contains various controls as follows (top to bottom): yeast total RNA, yeast tRNA, E. coli rRNA, E. coli DNA, poly r(A), human COT-1 DNA, human genomic DNA (100 ng), and human genomic DNA (500 ng)
Transcript map and sequence of non-SCLC LOH region B Zhao and G Bepler by pulsed-®eld gel electrophoresis, restriction enzyme mapping (NotI, BssHII, MluI), and STS mapping . Exon trapping resulted in the identi®cation of 55 exons. This method is based on the recognition of functional 5' and 3' splice sites in genomic DNA fragments cloned into the modi®ed splicing vector pSPL3 (Burn et al., 1995; Church et al., 1994) . This technique has successfully been used to identify novel genes, for instance the neuro®bromatosis 2 gene (Trofatter et al., 1993) . We were able to identify 20 of the 28 internal exons of the known genes in the LOH11A region (SSA/Ro52, RRM1, GOK), which attests to the power of this technology in gene identi®cation. Sixteen novel exons were identi®ed that were not part of repetitive DNA. The size of these exons ranged from 37 to 402 bp, and cDNA screening indicated the presence of tissue-speci®c transcripts for as many as eight exons (#8, #9, #29, #32, #34, #35, #37). These exons fall into three groups based on their hybridization pattern. Exons #8, #9, #29, and #37 were positive in lymph nodes, exons #32 ± 34 were positive in liver, prostate, testis, and leukemia, and exon #35 was positive in lymph node, testis, prostate, and liver. Taking the orientation and location of these exons into account, it is likely that they are part of ®ve novel and yet unidenti®ed genes in the region (see Figure 2) . Only three of the 16 novel exons identi®ed by exon trapping were also predicted by GrailEXP and GENSCAN (#29, #35, and #37). Otherwise, the concordance of exons with all three methods was restricted to those within known genes. This strengthens the expression data and suggests that these exons belong to three novel genes in the region (exons #29 and #35 are oriented in the same direction but have dierent tissuespeci®c expression patterns, and exon #37 is oriented in opposite direction). Northern blotting data suggest that exon #37 is part of a 250 bp mRNA species, and they also suggest that exon #33 is part of a 2.7 kb mRNA species. The absence of speci®c hybridization signals with probes for exons #29 and #35 in Northern blots indicates that these exons may be part of genes with highly restricted patterns of expression or very low levels of expression, or they may not be parts of genes at all.
GrailEXP and GENSCAN predicted 23 and 22 genes respectively. Both programs predicted the known three genes in the region, although GENSCAN did not separate RRM1 and GOK into two genes. The tendency of this program to fuse genes into one larger gene as previously been noted (http://grail.lsd.ornl.gov/ grailexp/; http://genes.mit.edu/GENSCAN.html). With one exception, GrailEXP predicted all internal exons accurately, and slightly overestimated the sizes of the ®rst and last exons. Results obtained with GENSCAN were similar, but the accuracy of predicting the Figure 4 Multiple tissue Northern blots hybridized with probes for exons #16, #33, and #37. Exon #16 resulted in a 1.4 kb band in all tissues, and it was most notable in prostate and testis. Exon #33 resulted in a dominant 2.7 kb band and a much weaker 3.2 kb band in testis only. Exon #37 hybridized to a 250 bp RNA in adrenal gland only. Exons #8 ± 9, #29, and #35 did not result in visible hybridization signals. A probe for the RRM1 gene was used as positive control, and it resulted in a 3.1 kb band (data not shown). Each lane contains 2 mg poly-A RNA from dierent human tissues as indicated. Blots were exposed for 72 h to phosphor screens at room temperature 
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GENSCAN provides the user with a probability estimate for each predicted exon. For 10 of the exons in the genes SSA/Ro52, RRM1, and GOK probability estimates were in excess of 0.99, and for each of these exons the predicted size was exactly correct. Only one additional exon had a probability of 40.99 (gene #20, Table 3 ). This putative single exon gene (ORF 1017 bp) was not predicted by GrailEXP, and it was not detected by exon trapping, as would be expected for single exon genes. A sequence analysis revealed that this gene has 100% sequence identity with ORF-1 of LINE-1 repeats. An additional 14 exons had probabilities 40.90. Nine of these were part of RRM1 or GOK, and all were exactly correct. The remaining ®ve were exons 8 and 33 of gene 22, exons 6 and 7 of gene 18, and the single exon gene #16. Exon 7 of gene 18 was also predicted in the same orientation and size by GrailEXP and exon trapping (see Figure 2 , ET#35). It is thus highly likely that this exon is part of a gene located at map position 253 kb.
Gene #16 (see Figure 2 , GS#16) was also predicted by GrailEXP. This putative single exon gene is one of the six HSPC182-like genes identi®ed by GrailEXP and GENSCAN. The probability estimates for these six genes were 0.102, 0.786, 0.448, 0.541, 0.856, and 0.932 respectively (centromere to telomere). They were very similar to each other (98% identity) and had 75% identity with the ORF of the HSPC182 gene. The 10 nucleotide substitutions observed in this cluster of six genes were silent in ®ve and resulted in aminoacid substitutions in the remaining ®ve (Thr-Pro, Arg-Lys, Glu-Gln, Arg-Cys, Ser-Phe). This suggests that this gene cluster is a result of multiple gene duplications, and that they may be transcribed and functional. In fact, evidence for expression was observed in multiple tissues, and Northern analysis showed evidence for a 1.4 kb mRNA species.
Interestingly, both gene prediction algorithms identi®ed sequences in the c-rad pseudo-gene. GrailEXP predicted a gene with two exons that co-localizes with the actual pseudo-gene, and GENSCAN predicted three exons in the same location that are part of a larger 9-exon gene. The orientation of the actual pseudo-gene and the predicted exons was the same for both algorithms.
Our initial attempts in the isolation and characterization of full-length cDNA clones by PCR and hybridization screening of a series of human tissueand cell line-speci®c expression libraries has been disappointing. This may be explained by a relatively low abundance or perhaps even complete absence of message for the sought after genes in most libraries. Alternative methods, such as rapid ampli®cation of cDNA ends (Chenchik et al., 1996; Matz et al., 1999) or RecA-mediated anity capture (Zhumabayeva et al., 1999) may have better success.
Our polymorphic marker and STS scan of a large number of lung cancer cell lines is in agreement with previous publications, which have described frequent allele loss but no homozygous deletion in the region (Ali et al., 1987; Bepler and Garcia-Blanco, 1994; Fearon et al., 1985; Fong et al., 1994; Karnik et al., 1998; Lu et al., 1997; Ludwig et al., 1991; Ranzani et al., 1993; Shibagaki et al., 1994; Shiraishi et al., 1987; Skinner et al., 1990; Tran and Newsham, 1996; Viel et al., 1992; Weston et al., 1989; Winqvist et al., 1993) . We found a lower than expected frequency of heterozygosity for the polymorphic markers D11S4932 and RRI9, which suggests that allele loss has occurred in a substantial number of cell lines. As previously suggested, the lack of homozygous deletions in the LOH11A region is at least partially explained by the presence of the RRM1 gene. This gene is required for enzymatic activity of the ribonucleotide reductase holoenzyme, and absence of this gene is incompatible with proliferation (Elledge et al., 1992; Stubbe, 1998) . Since the LOH11A target region is relatively small (310 kb), it is thus not surprising that a screen of 117 established long term cell lines did not provide evidence for a homozygous deletion.
In summary, we have completed 380 407 bp of contiguous sequence that covers the region of frequent allele loss in non-SCLC on chromosome segment 11p15.5. Our sequence analysis, exon trapping, computational gene search, and expression analyses con®rm that this region contains three known genes (SSA/Ro52, RRM1, and partially GOK) and one pseudo-gene (crad), and suggest that a cluster of 6 HSPC182-like genes and ®ve additional novel genes are present in the region. This number of 14 potential genes is three-times higher than the predicted average number of genes in the human genome (12 ± 15 per million base pairs) (Bork and Copley, 2001; Consortium, 2001; Venter et al., 2001) . However, genes are not randomly distributed in the genome but rather clustered into gene-rich and genepoor regions (Venter et al., 2001) , and this number is in agreement with previous estimates of approximately 45 ± 50 genes per million base pairs in the human genome (Dickson, 1999) . Only three genes are truly con®rmed in the region and the evidence for transcribed products of the remaining 11 putative genes is presented here. Our results provide a ®rm basis for further investigations and functional analyses of this important genomic region.
Materials and methods
Isolation and subcloning of PAC and BAC clones PAC clones (PAC-113G22, PAC-28C6, PAC-267B3) were isolated and subcloned as previously described . BAC clones (RP11-101E4, RP11-437G21, RP11-462E16, and RP11-23F23) were obtained from the Roswell Park human genomic BAC resource (http://bacpac.med.buffalo.edu/human/overview.html) (Frengen et al., 1999) . Insert sizes and restriction digest patterns (NotI, BssHII, MluI) were veri®ed by pulsed-®eld gel electrophoresis. BAC DNA was partially digested with Sau3AI and subcloned into pBluescript-II-SK(+) (Stratagene, La Jolla, CA, USA).
Sequencing
A modi®ed¯uorescent dideoxy-chain termination method (BigDye Terminator Cycle Sequencing; PE, Foster City, CA, USA) was used to end-sequence PAC and BAC clones with custom-designed SP6 and T7 promoter primers. Subclones containing completely digested EcoRI or partially digested Sau3AI fragments were sequenced with SP6 and T7 promoter primers (NEB, Beverly, MA, USA) using a standard uorescent dideoxy-chain termination method (PE, Foster City, CA, USA). Custom primers were designed as needed and synthesized in the Roswell Park Biopolymer Core Facility. Sequencing was done on an ABI Prism 377 DNA Sequencer. Manual dideoxy-chain termination sequencing (T7 Sequenase version 2.0, Amersham Life Science, Arlington Heights, IL, USA) was used for regions that could not be resolved by automated sequencing. All sequences were visually proofread. Sequences were then analysed and aligned using Sequencher software (Version 3.0, Gene Codes Corporation, Ann Arbor, MI, USA) and BLAST software (Altschul et al., 1990) .
Exon trapping
PAC DNA from each of the three clones (113G22, 28C6, 267B3) was partially digested with Sau3AI and separated in 1.0% agarose gels. Fragments ranging in size from 3.5 ± 5.5 kb were extracted (QIAquick Gel Extraction Kit; Qiagen) and shotgun cloned into the BamHI site of the exon trapping vector pSPL3 (Gibco/BRL, Gaithersburg, MD, USA) (Burn et al., 1995; Church et al., 1994) . Plasmid DNA was prepared from each of the PAC/pSPL3 sublibraries and transfected (LipofectACE reagent, Gibco/BRL) into COS-7 cells. Total RNA was extracted after 24 h with Trizol reagent (Gibco/ BRL). Trapped exons were ampli®ed with vector-speci®c primers after reverse transcription (RT ± PCR) and cloned using uracil DNA glycosylase into the pAMP10 cloning system (Gibco/BRL). Individual clones were PCR ampli®ed with the secondary PCR primers, and products were separated in 2.0% agarose gels. Clones containing putative exons (products larger than 177 bp) were sequenced, and those with inserts derived from vector or E. coli DNA were discarded.
